Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial
P
Pin Zhang
T
Tao Sun
Y
Ying Wang
W
Wei Li
Z
Zhongsheng Tong
S
Sneha Phadke
T
Trevor Feinstein
W
Wenyue Ma
P
Pengfei Guo
(The Hong Kong University of Science and Technology , , , ,)
M
Minhua Zhang
Y
Yong Yue
B
Binghe Xu
(Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing)
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 17, Issue 1
Published
February 06, 2026
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (12)
P
Pin Zhang
T
Tao Sun
Y
Ying Wang
W
Wei Li
Z
Zhongsheng Tong
S
Sneha Phadke
T
Trevor Feinstein
W
Wenyue Ma
P
Pengfei Guo
The Hong Kong University of Science and Technology , , , ,
M
Minhua Zhang
Y
Yong Yue
B
Binghe Xu
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3